Table 2.
Multivariate analysis of the pathological T-stage
| Parameter | Coefficient | 95% confidence interval | p Value |
|---|---|---|---|
| CRT [−] group | |||
| Age | 0.066 | −0.047 ~ 0.179 | 0.253 |
| Tumor locationa | 0.748 | −1.114 ~ 2.611 | 0.431 |
| Tumor gradeb | 2.139 | −1.393 ~ 5.671 | 0.235 |
| Tumor size | 0.715 | 0.038 ~ 1.392 | 0.038* |
| Tumor SUVmax | 0.894 | 0.400 ~ 1.389 | <0.001* |
| CRT [+] group | |||
| Age | −0.027 | −0.108 ~ 0.053 | 0.504 |
| Tumor locationa | 0.756 | −0.955 ~ 2.468 | 0.386 |
| Tumor gradeb | −1.661 | −3.814 ~ 0.493 | 0.131 |
| Tumor size | 0.206 | −0.425 ~ 0.837 | 0.523 |
| Tumor SUVmax | 1.111 | 0.530 ~ 1.692 | <0.001* |
aLower vs. Upper + Middle
bGrade 3 vs. Grade 1 + 2. Tumor histological grade was not assessment in patients with resected tumor specimens classified as T0
*Statistically significant
CRT chemoradiotherapy, SUV max maximal standardized uptake value